Onward Medical N.V. (ONWD.BR)
EUR 4.74
(-0.21%)
EUR 4.74
(-0.21%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -32.27 Million | -26.68 Million | -19.87 Million | -12.9 Million | -9.84 Million | -7.15 Million |
| Net Income | -36.07 Million | -33.53 Million | -34.24 Million | -19.99 Million | -13.44 Million | -9.89 Million |
| Depreciation & Amortization | 726 Thousand | 735 Thousand | 329 Thousand | 271 Thousand | 229 Thousand | 234 Thousand |
| Deferred income taxes | - | - | 28 Thousand | -84 Thousand | -142 Thousand | -80 Thousand |
| Stock-based compensation | 2.56 Million | 1.69 Million | 8.56 Million | 2.7 Million | 289 Thousand | 361 Thousand |
| Change in working capital | -1.16 Million | 2.95 Million | -261 Thousand | -269 Thousand | 551 Thousand | 734 Thousand |
| Other non-cash items | 808 Thousand | 1.47 Million | 5.71 Million | 4.47 Million | 2.67 Million | 1.48 Million |
| Investing Cash Flow | 19.57 Million | -20.41 Million | -2.32 Million | -173 Thousand | -99 Thousand | -103 Thousand |
| Investments in PPE | -422 Thousand | -417 Thousand | -2.32 Million | -173 Thousand | -124 Thousand | -103 Thousand |
| Acquisitions | - | - | - | - | 25 Thousand | - |
| Investment purchases | - | -20 Million | - | - | - | - |
| Sales/Maturities of investments | 20 Million | - | - | - | - | - |
| Other Investing Activities | 20 Million | -20 Million | -2.23 Million | - | - | - |
| Financing Cash Flow | 813 Thousand | -557 Thousand | 105.36 Million | 4.36 Million | 16.4 Million | 8.64 Million |
| Debt repayment | -1.29 Million | -557 Thousand | -30 Million | -3.94 Million | -11.74 Million | -5.48 Million |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | 80.1 Million | 548 Thousand | 4.75 Million | 3.2 Million |
| Other Financing Activities | -479 Thousand | -557 Thousand | 55.25 Million | 7.76 Million | 23.39 Million | 5.44 Million |
| Accounts receivables | 491 Thousand | 140 Thousand | -2.35 Million | -221 Thousand | -24 Thousand | -118 Thousand |
| Accounts payables | -1.65 Million | 2.81 Million | 2.09 Million | -48 Thousand | 575 Thousand | 852 Thousand |
| Inventory | - | - | - | - | - | - |
| Other working capital | -1.65 Million | - | - | - | - | - |
| Cash at beginning of period | 41.76 Million | 89.44 Million | 6.38 Million | 15.12 Million | 8.66 Million | 7.27 Million |
| Cash at end of period | 29.76 Million | 41.76 Million | 89.44 Million | 6.38 Million | 15.12 Million | 8.66 Million |
| Capital Expenditure | -422 Thousand | -417 Thousand | -2.32 Million | -173 Thousand | -124 Thousand | -103 Thousand |
| Effect of forex changes on cash | -113 Thousand | -24 Thousand | -100 Thousand | -41 Thousand | 5000.00 | 3000.00 |
| Net cash flow / Change in cash | -11.99 Million | -47.68 Million | 83.06 Million | -8.74 Million | 6.46 Million | 1.39 Million |
| Free Cash Flow | -32.69 Million | -27.1 Million | -22.19 Million | -13.07 Million | -9.96 Million | -7.25 Million |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -9.12 Million | -9.12 Million | -36.07 Million | -8.44 Million | -8.44 Million | -19.28 Million |
| Depreciation & Amortization | 217 Thousand | 217 Thousand | 726 Thousand | 198.5 Thousand | 198.5 Thousand | 329 Thousand |
| Deferred income taxes | - | - | - | - | - | -2.52 Million |
| Stock-based compensation | 664.5 Thousand | 664.5 Thousand | 2.56 Million | 696.5 Thousand | 696.5 Thousand | 585.5 Thousand |
| Change in working capital | -414 Thousand | -414 Thousand | -1.16 Million | 528.5 Thousand | 528.5 Thousand | -1.27 Million |
| Other non-cash items | 1.25 Million | 1.25 Million | 808 Thousand | 86.5 Thousand | 86.5 Thousand | 3.77 Million |
| Investing Cash Flow | -3.76 Million | -3.76 Million | 19.57 Million | 12.44 Million | 12.44 Million | -5.3 Million |
| Investments in PPE | -12 Thousand | -12 Thousand | -422 Thousand | -67.5 Thousand | -67.5 Thousand | -303 Thousand |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | 20 Million | - | - | - |
| Other Investing Activities | -3.75 Million | -3.75 Million | 20 Million | 12.5 Million | 12.5 Million | -5 Million |
| Financing Cash Flow | 8.82 Million | 8.82 Million | 813 Thousand | 19 Thousand | 19 Thousand | 774 Thousand |
| Debt repayment | - | - | -1.29 Million | -255 Thousand | - | -1.03 Million |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | 17.94 Million | - | - | - | - | - |
| Other Financing Activities | 8.82 Million | 8.82 Million | - | 19 Thousand | 19 Thousand | 387.5 Thousand |
| Accounts receivables | -414 Thousand | -414 Thousand | 491 Thousand | 528.5 Thousand | 528.5 Thousand | -566 Thousand |
| Accounts payables | 3.1 Million | - | -1.65 Million | -941 Thousand | - | -713 Thousand |
| Inventory | - | - | - | - | - | - |
| Other working capital | - | - | - | - | - | - |
| Cash at beginning of period | 29.76 Million | - | 41.76 Million | 18.78 Million | - | 41.76 Million |
| Cash at end of period | 24.55 Million | -2.6 Million | 29.76 Million | 29.76 Million | 5.48 Million | 18.78 Million |
| Capital Expenditure | -12 Thousand | -12 Thousand | -422 Thousand | -67.5 Thousand | -67.5 Thousand | -303 Thousand |
| Effect of forex changes on cash | -263.5 Thousand | -263.5 Thousand | -113 Thousand | -30.5 Thousand | -30.5 Thousand | -26 Thousand |
| Net cash flow / Change in cash | -5.21 Million | -2.6 Million | -11.99 Million | 10.98 Million | 5.48 Million | -22.97 Million |
| Free Cash Flow | -7.41 Million | -7.41 Million | -32.69 Million | -7 Million | -7 Million | -18.69 Million |
000338
VLVLY
LIME
600261
CLIME-B
BRE